Global and United States Anticoagulant Injections Market Report & Forecast 2022-2028

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Market Analysis and Insights: Global and United States Anticoagulant Injections Market
This report focuses on global and United States Anticoagulant Injections market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Anticoagulant Injections market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, LMWH accounting for % of the Anticoagulant Injections global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, VTE was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Anticoagulant Injections market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period 2022-2028.

Global Anticoagulant Injections Scope and Market Size
Anticoagulant Injections market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Anticoagulant Injections market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Anticoagulant Injections market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    LMWH
    Unfractionated Heparin
    Fibrinolytics
    Other

Segment by Application
    VTE
    ACS/MI
    AF
    Other

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Sanofi
    Genentech (Roche)
    Boehringer Ingelheim
    Aspen
    Pfizer
    Hepalink
    King-friend
    CSBIO
    Amphastar Pharmaceuticals

 1 Study Coverage
    1.1 Anticoagulant Injections Revenue in Anticoagulant Injections Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Anticoagulant Injections Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Anticoagulant Injections Market Size for the Year 2017-2028
        1.2.2 Global Anticoagulant Injections Market Size for the Year 2017-2028
    1.3 Anticoagulant Injections Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Anticoagulant Injections in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Anticoagulant Injections Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Anticoagulant Injections Market Dynamics
        1.4.1 Anticoagulant Injections Industry Trends
        1.4.2 Anticoagulant Injections Market Drivers
        1.4.3 Anticoagulant Injections Market Challenges
        1.4.4 Anticoagulant Injections Market Restraints
    1.5 Study Objectives
    1.6 Years Considered

 2 Anticoagulant Injections by Type
    2.1 Anticoagulant Injections Market Segment by Type
        2.1.1 LMWH
        2.1.2 Unfractionated Heparin
        2.1.3 Fibrinolytics
        2.1.4 Other
    2.2 Global Anticoagulant Injections Market Size by Type (2017, 2022 & 2028)
    2.3 Global Anticoagulant Injections Market Size by Type (2017-2028)
    2.4 United States Anticoagulant Injections Market Size by Type (2017, 2022 & 2028)
    2.5 United States Anticoagulant Injections Market Size by Type (2017-2028)

 3 Anticoagulant Injections by Application
    3.1 Anticoagulant Injections Market Segment by Application
        3.1.1 VTE
        3.1.2 ACS/MI
        3.1.3 AF
        3.1.4 Other
    3.2 Global Anticoagulant Injections Market Size by Application (2017, 2022 & 2028)
    3.3 Global Anticoagulant Injections Market Size by Application (2017-2028)
    3.4 United States Anticoagulant Injections Market Size by Application (2017, 2022 & 2028)
    3.5 United States Anticoagulant Injections Market Size by Application (2017-2028)

 4 Global Anticoagulant Injections Competitor Landscape by Company
    4.1 Global Anticoagulant Injections Market Size by Company
        4.1.1 Top Global Anticoagulant Injections Companies Ranked by Revenue (2021)
        4.1.2 Global Anticoagulant Injections Revenue by Player (2017-2022)
    4.2 Global Anticoagulant Injections Concentration Ratio (CR)
        4.2.1 Anticoagulant Injections Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Anticoagulant Injections in 2021
        4.2.3 Global Anticoagulant Injections Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Anticoagulant Injections Headquarters, Revenue in Anticoagulant Injections Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Anticoagulant Injections Headquarters and Area Served
        4.3.2 Global Anticoagulant Injections Companies Revenue in Anticoagulant Injections Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Anticoagulant Injections Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Anticoagulant Injections Market Size by Company
        4.5.1 Top Anticoagulant Injections Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Anticoagulant Injections Revenue by Players (2020, 2021 & 2022)

 5 Global Anticoagulant Injections Market Size by Region
    5.1 Global Anticoagulant Injections Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Anticoagulant Injections Market Size by Region (2017-2028)
        5.2.1 Global Anticoagulant Injections Market Size by Region: 2017-2022
        5.2.2 Global Anticoagulant Injections Market Size by Region (2023-2028)

 6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Anticoagulant Injections Market Size YoY Growth 2017-2028
        6.1.2 North America Anticoagulant Injections Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 United States
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Anticoagulant Injections Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Anticoagulant Injections Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 China Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
    6.3 Europe
        6.3.1 Europe Anticoagulant Injections Market Size YoY Growth 2017-2028
        6.3.2 Europe Anticoagulant Injections Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Anticoagulant Injections Market Size YoY Growth 2017-2028
        6.4.2 Latin America Anticoagulant Injections Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Anticoagulant Injections Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Anticoagulant Injections Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE

 7 Company Profiles
    7.1 Sanofi
        7.1.1 Sanofi Company Details
        7.1.2 Sanofi Business Overview
        7.1.3 Sanofi Anticoagulant Injections Introduction
        7.1.4 Sanofi Revenue in Anticoagulant Injections Business (2017-2022)
        7.1.5 Sanofi Recent Development
    7.2 Genentech (Roche)
        7.2.1 Genentech (Roche) Company Details
        7.2.2 Genentech (Roche) Business Overview
        7.2.3 Genentech (Roche) Anticoagulant Injections Introduction
        7.2.4 Genentech (Roche) Revenue in Anticoagulant Injections Business (2017-2022)
        7.2.5 Genentech (Roche) Recent Development
    7.3 Boehringer Ingelheim
        7.3.1 Boehringer Ingelheim Company Details
        7.3.2 Boehringer Ingelheim Business Overview
        7.3.3 Boehringer Ingelheim Anticoagulant Injections Introduction
        7.3.4 Boehringer Ingelheim Revenue in Anticoagulant Injections Business (2017-2022)
        7.3.5 Boehringer Ingelheim Recent Development
    7.4 Aspen
        7.4.1 Aspen Company Details
        7.4.2 Aspen Business Overview
        7.4.3 Aspen Anticoagulant Injections Introduction
        7.4.4 Aspen Revenue in Anticoagulant Injections Business (2017-2022)
        7.4.5 Aspen Recent Development
    7.5 Pfizer
        7.5.1 Pfizer Company Details
        7.5.2 Pfizer Business Overview
        7.5.3 Pfizer Anticoagulant Injections Introduction
        7.5.4 Pfizer Revenue in Anticoagulant Injections Business (2017-2022)
        7.5.5 Pfizer Recent Development
    7.6 Hepalink
        7.6.1 Hepalink Company Details
        7.6.2 Hepalink Business Overview
        7.6.3 Hepalink Anticoagulant Injections Introduction
        7.6.4 Hepalink Revenue in Anticoagulant Injections Business (2017-2022)
        7.6.5 Hepalink Recent Development
    7.7 King-friend
        7.7.1 King-friend Company Details
        7.7.2 King-friend Business Overview
        7.7.3 King-friend Anticoagulant Injections Introduction
        7.7.4 King-friend Revenue in Anticoagulant Injections Business (2017-2022)
        7.7.5 King-friend Recent Development
    7.8 CSBIO
        7.8.1 CSBIO Company Details
        7.8.2 CSBIO Business Overview
        7.8.3 CSBIO Anticoagulant Injections Introduction
        7.8.4 CSBIO Revenue in Anticoagulant Injections Business (2017-2022)
        7.8.5 CSBIO Recent Development
    7.9 Amphastar Pharmaceuticals
        7.9.1 Amphastar Pharmaceuticals Company Details
        7.9.2 Amphastar Pharmaceuticals Business Overview
        7.9.3 Amphastar Pharmaceuticals Anticoagulant Injections Introduction
        7.9.4 Amphastar Pharmaceuticals Revenue in Anticoagulant Injections Business (2017-2022)
        7.9.5 Amphastar Pharmaceuticals Recent Development

 8 Research Findings and Conclusion

 9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Anticoagulant Injections Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Anticoagulant Injections Market Trends
    Table 3. Anticoagulant Injections Market Drivers
    Table 4. Anticoagulant Injections Market Challenges
    Table 5. Anticoagulant Injections Market Restraints
    Table 6. Global Anticoagulant Injections Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Anticoagulant Injections Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Anticoagulant Injections Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Anticoagulant Injections Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Anticoagulant Injections Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Anticoagulant Injections Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Anticoagulant Injections Revenue Share by Player, 2017-2022
    Table 13. Global Anticoagulant Injections Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Anticoagulant Injections by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anticoagulant Injections as of 2021)
    Table 15. Top Players of Anticoagulant Injections in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Anticoagulant Injections Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Anticoagulant Injections Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Anticoagulant Injections Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Anticoagulant Injections Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Anticoagulant Injections Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Anticoagulant Injections Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Anticoagulant Injections Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Anticoagulant Injections Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Anticoagulant Injections Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Anticoagulant Injections Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Anticoagulant Injections Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Anticoagulant Injections Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Anticoagulant Injections Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Sanofi Company Details
    Table 31. Sanofi Business Overview
    Table 32. Sanofi Anticoagulant Injections Product
    Table 33. Sanofi Revenue in Anticoagulant Injections Business (2017-2022) & (US$ Million)
    Table 34. Sanofi Recent Development
    Table 35. Genentech (Roche) Company Details
    Table 36. Genentech (Roche) Business Overview
    Table 37. Genentech (Roche) Anticoagulant Injections Product
    Table 38. Genentech (Roche) Revenue in Anticoagulant Injections Business (2017-2022) & (US$ Million)
    Table 39. Genentech (Roche) Recent Development
    Table 40. Boehringer Ingelheim Company Details
    Table 41. Boehringer Ingelheim Business Overview
    Table 42. Boehringer Ingelheim Anticoagulant Injections Product
    Table 43. Boehringer Ingelheim Revenue in Anticoagulant Injections Business (2017-2022) & (US$ Million)
    Table 44. Boehringer Ingelheim Recent Development
    Table 45. Aspen Company Details
    Table 46. Aspen Business Overview
    Table 47. Aspen Anticoagulant Injections Product
    Table 48. Aspen Revenue in Anticoagulant Injections Business (2017-2022) & (US$ Million)
    Table 49. Aspen Recent Development
    Table 50. Pfizer Company Details
    Table 51. Pfizer Business Overview
    Table 52. Pfizer Anticoagulant Injections Product
    Table 53. Pfizer Revenue in Anticoagulant Injections Business (2017-2022) & (US$ Million)
    Table 54. Pfizer Recent Development
    Table 55. Hepalink Company Details
    Table 56. Hepalink Business Overview
    Table 57. Hepalink Anticoagulant Injections Product
    Table 58. Hepalink Revenue in Anticoagulant Injections Business (2017-2022) & (US$ Million)
    Table 59. Hepalink Recent Development
    Table 60. King-friend Company Details
    Table 61. King-friend Business Overview
    Table 62. King-friend Anticoagulant Injections Product
    Table 63. King-friend Revenue in Anticoagulant Injections Business (2017-2022) & (US$ Million)
    Table 64. King-friend Recent Development
    Table 65. CSBIO Company Details
    Table 66. CSBIO Business Overview
    Table 67. CSBIO Anticoagulant Injections Product
    Table 68. CSBIO Revenue in Anticoagulant Injections Business (2017-2022) & (US$ Million)
    Table 69. CSBIO Recent Development
    Table 70. Amphastar Pharmaceuticals Company Details
    Table 71. Amphastar Pharmaceuticals Business Overview
    Table 72. Amphastar Pharmaceuticals Anticoagulant Injections Product
    Table 73. Amphastar Pharmaceuticals Revenue in Anticoagulant Injections Business (2017-2022) & (US$ Million)
    Table 74. Amphastar Pharmaceuticals Recent Development
    Table 75. Research Programs/Design for This Report
    Table 76. Key Data Information from Secondary Sources
    Table 77. Key Data Information from Primary Sources
List of Figures
    Figure 1. Anticoagulant Injections Product Picture
    Figure 2. Global Anticoagulant Injections Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Anticoagulant Injections Market Size 2017-2028 (US$ Million)
    Figure 4. United States Anticoagulant Injections Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Anticoagulant Injections Market Size 2017-2028 (US$ Million)
    Figure 6. United States Anticoagulant Injections Market Share in Global 2017-2028
    Figure 7. Anticoagulant Injections Report Years Considered
    Figure 8. Product Picture of LMWH
    Figure 9. Product Picture of Unfractionated Heparin
    Figure 10. Product Picture of Fibrinolytics
    Figure 11. Product Picture of Other
    Figure 12. Global Anticoagulant Injections Market Share by Type in 2022 & 2028
    Figure 13. Global Anticoagulant Injections Market Size by Type (2017-2028) & (US$ Million)
    Figure 14. Global Anticoagulant Injections Market Share by Type (2017-2028)
    Figure 15. United States Anticoagulant Injections Market Share by Type in 2022 & 2028
    Figure 16. United States Anticoagulant Injections Market Size by Type (2017-2028) & (US$ Million)
    Figure 17. United States Anticoagulant Injections Market Share by Type (2017-2028)
    Figure 18. Product Picture of VTE
    Figure 19. Product Picture of ACS/MI
    Figure 20. Product Picture of AF
    Figure 21. Product Picture of Other
    Figure 22. Global Anticoagulant Injections Market Share by Application in 2022 & 2028
    Figure 23. Global Anticoagulant Injections Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. Global Anticoagulant Injections Market Share by Application (2017-2028)
    Figure 25. United States Anticoagulant Injections Market Share by Application in 2022 & 2028
    Figure 26. United States Anticoagulant Injections Market Size by Application (2017-2028) & (US$ Million)
    Figure 27. United States Anticoagulant Injections Market Share by Application (2017-2028)
    Figure 28. North America Anticoagulant Injections Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. United States Anticoagulant Injections Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Canada Anticoagulant Injections Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Europe Anticoagulant Injections Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 32. Germany Anticoagulant Injections Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. France Anticoagulant Injections Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. U.K. Anticoagulant Injections Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Italy Anticoagulant Injections Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Russia Anticoagulant Injections Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Asia-Pacific Anticoagulant Injections Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 38. China Anticoagulant Injections Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Japan Anticoagulant Injections Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. South Korea Anticoagulant Injections Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. India Anticoagulant Injections Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Australia Anticoagulant Injections Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. China Taiwan Anticoagulant Injections Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Indonesia Anticoagulant Injections Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Thailand Anticoagulant Injections Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Malaysia Anticoagulant Injections Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Latin America Anticoagulant Injections Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 48. Mexico Anticoagulant Injections Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Brazil Anticoagulant Injections Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Argentina Anticoagulant Injections Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa Anticoagulant Injections Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 52. Turkey Anticoagulant Injections Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Anticoagulant Injections Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. UAE Anticoagulant Injections Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Sanofi Revenue Growth Rate in Anticoagulant Injections Business (2017-2022)
    Figure 56. Genentech (Roche) Revenue Growth Rate in Anticoagulant Injections Business (2017-2022)
    Figure 57. Boehringer Ingelheim Revenue Growth Rate in Anticoagulant Injections Business (2017-2022)
    Figure 58. Aspen Revenue Growth Rate in Anticoagulant Injections Business (2017-2022)
    Figure 59. Pfizer Revenue Growth Rate in Anticoagulant Injections Business (2017-2022)
    Figure 60. Hepalink Revenue Growth Rate in Anticoagulant Injections Business (2017-2022)
    Figure 61. King-friend Revenue Growth Rate in Anticoagulant Injections Business (2017-2022)
    Figure 62. CSBIO Revenue Growth Rate in Anticoagulant Injections Business (2017-2022)
    Figure 63. Amphastar Pharmaceuticals Revenue Growth Rate in Anticoagulant Injections Business (2017-2022)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed

Market Analysis and Insights: Global and United States Anticoagulant Injections Market
This report focuses on global and United States Anticoagulant Injections market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Anticoagulant Injections market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, LMWH accounting for % of the Anticoagulant Injections global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, VTE was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Anticoagulant Injections market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period 2022-2028.

Global Anticoagulant Injections Scope and Market Size
Anticoagulant Injections market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Anticoagulant Injections market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Anticoagulant Injections market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    LMWH
    Unfractionated Heparin
    Fibrinolytics
    Other

Segment by Application
    VTE
    ACS/MI
    AF
    Other

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Sanofi
    Genentech (Roche)
    Boehringer Ingelheim
    Aspen
    Pfizer
    Hepalink
    King-friend
    CSBIO
    Amphastar Pharmaceuticals